PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation

Annals of Neurology

Volumn 76, Issue 3, 2014, Pages 379-392

  Jun, Gyungah ^a,b   Asai, Hirohide ^a   Zeldich, Ella ^a   Drapeau, Elodie ^c   Chen, CiDi ^a   Chung, Jaeyoon ^a   Park, Jong Ho ^d   Kim, Sehwa ^d   Haroutunian, Vahram ^c   Foroud, Tatiana ^e   Kuwano, Ryozo ^f   Haines, Jonathan L ^g   Pericak Vance, Margaret A ^h   Schellenberg, Gerard D ⁱ   Lunetta, Kathryn L ^b   Kim, Jong Won ^d,j   Buxbaum, Joseph D ^c   Mayeux, Richard ^k   Ikezu, Tsuneya ^a   Abraham, Carmela R ^a   Farrer, Lindsay A ^a,b   more..

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NIIGATA UNIVERSITY   (Japan)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j Sungkyunkwan University School of Medicine   (South Korea)

^k Howard Hughes Medical Institute   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOENZYME; APOLIPOPROTEIN E; SEMAPHORIN 3A; TAU PROTEIN; CELL SURFACE RECEPTOR; ISOPROTEIN; PLXNA4 PROTEIN, HUMAN;

AFRICAN; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASIAN AMERICAN; CAUCASIAN; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IGSF21 GENE; IMMUNOBLOTTING; ITIH3 GENE; MALE; MIDDLE FRONTAL GYRUS; MYO18B GENE; NERVE CELL CULTURE; NONHUMAN; ONSET AGE; PHENOTYPE; PLXNA4 GENE; PROTEIN PHOSPHORYLATION; QUANTITATIVE TRAIT; RAT; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; COHORT ANALYSIS; CYTOLOGY; FRONTAL LOBE; GENETIC PREDISPOSITION; GENETICS; HIPPOCAMPUS; METABOLISM; PATHOLOGY; PEDIGREE; PHOSPHORYLATION; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COHORT STUDIES; FEMALE; FRONTAL LOBE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MALE; PEDIGREE; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RATS; RECEPTORS, CELL SURFACE; TAU PROTEINS;

EID: 84907879194     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24219     Document Type: Article

References (47)

1. Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 2011;7:208-244.
2. Farrer LA. Genetics and the dementia patient. Neurologist 1997;3:13-30.
3. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
4. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45:1452-1458.
5. Lill CM, Bertram L. Towards unveiling the genetics of neurodegenerative diseases. Semin Neurol 2012;31:531-541.
6. Paulson HL, Igo I. Genetics of dementia. Semin Neurol 2012;31:449-460.
7. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with lateonset Alzheimer's disease. Nat Genet 2011;43:436-441.
8. So HC, Gui AH, Cherny SS, Sham PC. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 2011;35:310-317.
9. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-753.
10. Sherva R, Farrer LA. Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease. Curr Psychiatry Rep 2011;13:138-146.
11. Choi SH, Liu C, Dupuis J, et al. Using linkage analysis of large pedigrees to guide association analyses. BMC Proc 2011;5(suppl 9):S79.
12. Cobb JL, Wolf PA, Au R, et al. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
13. Wijsman EM, Pankratz ND, Choi Y, et al. Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 2011;7:e1001308.
14. Miyashita A, Koike A, Jun G, et al. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One 2013;8:e58618.
15. Reitz C, Jun G, Naj A, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. JAMA 2013;309:1483-1492.
16. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010;303:1832-1840.
17. Jun G, Naj AC, Beecham GW, et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010;67:1473-1484.
18. Li Y, Abecasis GR. Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet 2006;S79:2290.
19. Jun G, Moncaster JA, Koutras C, et al. Delta-catenin is genetically and biologically associated with cortical cataract and future Alzheimer-related structural and functional brain changes. PLoS One 2012;7:e43728.
20. Hanson RL, Knowler WC. Analytic strategies to detect linkage to a common disorder with genetically determined age of onset: diabetes mellitus in Pima Indians. Genet Epidemiol 1998;15:299-315.
21. Jiang Y, Zhang H. Propensity score-based nonparametric test revealing genetic variants underlying bipolar disorder. Genet Epidemiol 2011;35:125-132.
22. Schnell AH, Sun X, Igo RP Jr, Elston RC. Some capabilities for model-based and model-free linkage analysis using the program package S.A.G.E. (Statistical Analysis for Genetic Epidemiology). Hum Hered 2011;72:237-246.
23. Jun G, Guo H, Klein BE, et al. EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet 2009;5:e1000584.
24. Morris NJ, Elston R, Stein CM. Calculating asymptotic significance levels of the constrained likelihood ratio test with application to multivariate genetic linkage analysis. Stat Appl Genet Mol Biol 2009;8:Article 39.
25. Wang T, Elston RC. Two-level Haseman-Elston regression for general pedigree data analysis. Genet Epidemiol 2005;29:12-22.
26. Liu JZ, McRae AF, Nyholt DR, et al. A versatile gene-based test for genome-wide association studies. AmJ Hum Genet 2010;87:139-145.
27. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191.
28. So PP, Zeldich E, Seyb KI, et al. Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-beta precursor protein dimerization. Am J Neurodegener Dis 2012;1:75-87.
29. Sato S, Xu J, Okuyama S, et al. Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. J Neurosci 2008;28:14511-14521.
30. Haroutunian V, Perl DP, Purohit DP, et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 1998;55:1185-1191.
31. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999;99:71-80.
32. Suto F, Ito K, Uemura M, et al. Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci 2005;25:3628-3637.
33. Good PF, Alapat D, Hsu A, et al. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J Neurochem 2004;91:716-736.
34. Cole AR, Knebel A, Morrice NA, et al. GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J Biol Chem 2004;279:50176-50180.
35. Hirsch E, Hu LJ, Prigent A, et al. Distribution of semaphorin IV in adult human brain. Brain Res 1999;823:67-79.
36. Low LK, Liu XB, Faulkner RL, et al. Plexin signaling selectively regulates the stereotyped pruning of corticospinal axons from visual cortex. Proc Natl Acad Sci U S A 2008;105:8136-8141.
37. Sasaki Y, Cheng C, Uchida Y, et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002;35:907-920.
38. Waimey KE, Huang PH, Chen M, Cheng HJ. Plexin-A3 and plexin-A4 restrict the migration of sympathetic neurons but not their neural crest precursors. Dev Biol 2008;315:448-458.
39. Takahashi T, Fournier A, Nakamura F, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999;99:59-69.
40. Schulte EC, Stahl I, Czamara D, et al. Rare variants in PLXNA4 and Parkinson's disease. PLoS One 2013;8:e79145.
41. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011;43:429-435.
42. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007;39:168-177.
43. Schulze TG, Detera-Wadleigh SD, Akula N, et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 2009;14:487-491.
44. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589.
45. Arimura N, Menager C, Kawano Y, et al. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol 2005;25:9973-9984.
46. Brown M, Jacobs T, Eickholt B, et al. Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse. J Neurosci 2004;24:8994-9004.
47. Uchida Y, Ohshima T, Sasaki Y, et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 2005;10:165-179.